| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BridgeBio Pharma, Inc. | President and CFO | Common Stock | 383K | $25.6M | $66.84 | Nov 17, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| BBIO | BridgeBio Pharma, Inc. | Nov 16, 2025 | 3 | -$2.54M | 4 | Nov 18, 2025 | President and CFO |
| BBIO | BridgeBio Pharma, Inc. | Aug 21, 2025 | 1 | -$2.09M | 4 | Aug 22, 2025 | President and CFO |
| BBIO | BridgeBio Pharma, Inc. | Aug 16, 2025 | 3 | -$1.97M | 4 | Aug 19, 2025 | President and CFO |
| BBIO | BridgeBio Pharma, Inc. | May 16, 2025 | 1 | -$721K | 4 | May 20, 2025 | President and CFO |
| BBIO | BridgeBio Pharma, Inc. | Mar 19, 2025 | 1 | $0 | 4 | Mar 21, 2025 | President and CFO |
| BBIO | BridgeBio Pharma, Inc. | Feb 16, 2025 | 1 | -$481K | 4 | Feb 19, 2025 | President and COO |
| BBIO | BridgeBio Pharma, Inc. | Dec 10, 2024 | 1 | $0 | 4 | Dec 12, 2024 | President and COO |
| BBIO | BridgeBio Pharma, Inc. | Nov 16, 2024 | 1 | -$425K | 4 | Nov 19, 2024 | President and COO |
| BBIO | BridgeBio Pharma, Inc. | Aug 16, 2024 | 1 | -$438K | 4 | Aug 20, 2024 | President and COO |
| BBIO | BridgeBio Pharma, Inc. | Aug 6, 2024 | 2 | $0 | 4 | Aug 8, 2024 | President and COO |
| BBIO | BridgeBio Pharma, Inc. | Jul 23, 2024 | 0 | $0 | 3 | Jul 29, 2024 | President and COO |